Biosyent Inc Cash Flow Statement

RX C$7.35 -0.2 -2.0%

05/03/21

Balanced, Small Cap, Style Neutral

Market Cap £54.3m

Enterprise Value £41.8m

Revenue £12.7m

Quality

Value

Momentum

StockRank™

To unlock Biosyent Inc's cashflow statement please upgrade your membership.

	2014	2015	2016	2017	2018	2019
Period End:	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	CAD	CAD	CAD	CAD	CAD	CAD

Net Income/Starting Line

Depreciation/Depletion
Amortization
Deferred Taxes
Non-Cash Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Inventories
Prepaid Expenses
Payable/Accrued
Other Liabilities
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Other Investing Cash Flow Items, Total
Sale/Maturity of Investment
Investment, Net
Purchase of Investments
Intangible, Net
Other Investing Cash Flow
Cash from Investing Activities

Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.